⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4119859 | 0.78 | — | — | |
| SCHEMBL27553905 | 0.78 | — | — | |
| SCHEMBL4119855 | 0.78 | — | — | |
| SCHEMBL6671473 | 0.78 | — | — | |
| SCHEMBL6671483 | 0.78 | — | — | |
| SCHEMBL10398570 | 0.75 | — | — | |
| SCHEMBL9426 | 0.72 | — | — | |
| SCHEMBL269447 | 0.72 | — | — | |
| SCHEMBL337523 | 0.72 | — | — | |
| SCHEMBL263463 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130256015-A1 | CELLULOSIC PRINTED CIRCUIT BOARD MATERIALS HAVING BORONATE MOIETIES | Empire Technology Developement LLC | 2013-10-03 | — | — | US | claimed |
| WO-2013147798-A1 | CELLULOSIC PRINTED CIRCUIT BOARD MATERIALS HAVING BORONATE MOIETIES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-10-03 | — | — | WO | claimed |
| EP-2429993-B1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGELHEIM INT (DE) | 2015-01-21 | — | — | EP | disclosed |
| EP-2417140-B1 | INHIBITORS OF HIV REPLICATION | BOEHRINGER INGELHEIM INT (DE) | 2014-11-26 | — | — | EP | disclosed |
| US-8841331-B2 | Inhibitors of human immunodeficiency virus replication | GILEAD SCIENCES, INC. (US) | 2014-09-23 | — | — | US | disclosed |
| US-20130256015-A1 | CELLULOSIC PRINTED CIRCUIT BOARD MATERIALS HAVING BORONATE MOIETIES | Empire Technology Developement LLC | 2013-10-03 | — | — | US | disclosed |
| WO-2013147798-A1 | CELLULOSIC PRINTED CIRCUIT BOARD MATERIALS HAVING BORONATE MOIETIES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-10-03 | — | — | WO | disclosed |
| US-20130203747-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | GILEAD SCIENCES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-8349839-B2 | Inhibitors of HIV replication | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-01-08 | — | — | US | disclosed |
| US-8338441-B2 | Inhibitors of human immunodeficiency virus replication | GILEAD SCIENCES, INC. (US) | 2012-12-25 | — | — | US | disclosed |
| US-8173684-B2 | Pyridone derivatives as p38α MAPK inhibitors | ASTELLAS PHARMA INC. (JP) | 2012-05-08 | — | — | US | disclosed |
| US-5359058-A | A cephalosporin compound substituted in the 7-position with a (cyclo)alkylideneammonio group | GIST-BROCADES, N.V. (NL) | 1994-10-25 | — | — | US | disclosed |
| US-5164494-A | Antibiotics | GIST-BROCADES N.V. (NL) | 1992-11-17 | — | — | US | disclosed |
| US-4921954-A | FROM SULFOXIDE INTERMEDIATE | GIST-BROCADES N.V. (NL) | 1990-05-01 | — | — | US | disclosed |
| EP-0300546-A1 | Process for the preparation of cephem compounds and cephalosporin derivatives | GIST-BROCADES N.V. (NL) | 1989-01-25 | — | — | EP | disclosed |
| US-4370332-A | MUSCLE RELAXANTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-01-25 | — | — | US | disclosed |
| US-4292320-A | SMOOTH MUSCLE RELAXANTS | FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1981-09-29 | — | — | US | disclosed |
| US-3988373-A | PLANT GROWTH REGULATORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-10-26 | — | — | US | disclosed |
| US-3978063-A | 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-08-31 | — | — | US | disclosed |
| US-3963725-A | 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-06-15 | — | — | US | disclosed |